FILGRASTIM-AAFI for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 6 adverse event reports in the FDA FAERS database where FILGRASTIM-AAFI was used for Neoplasm malignant.

Most Reported Side Effects for FILGRASTIM-AAFI

Side Effect	Reports	%	Deaths	Hosp.
Death	63	14.4%	62	3
Off label use	63	14.4%	9	4
White blood cell count decreased	28	6.4%	0	8
Hospitalisation	17	3.9%	1	16
Bone pain	15	3.4%	0	1
Malaise	15	3.4%	1	4
Needle issue	15	3.4%	0	0
Pyrexia	15	3.4%	1	12
Pain	14	3.2%	0	2
Device leakage	11	2.5%	0	0
Drug dose omission by device	11	2.5%	0	0
Illness	11	2.5%	1	1
Neoplasm malignant	11	2.5%	5	3
Drug ineffective	10	2.3%	1	1
Diarrhoea	9	2.1%	2	5